FIH Trial of VERT-002 in Patients With Locally Advanced or Metastatic Solid Tumors With MET Alterations
Recruiting
The goal of this clinical trial is to investigate the safety, the activity of VERT-002, and the optimal safe dose to be used, in participants with solid tumors including non-small cell lung cancer.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/29/2025
Locations: Gabrail Cancer Research Center, Canton, Ohio +17 locations
Conditions: Solid Tumor, MET Alteration
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
Recruiting
The goal of this prospective pragmatic randomized clinical trial is to determine if preoperative administration of tranexamic acid (TXA) reduces bleeding during and after major colorectal surgery. The primary questions are: * Does TXA reduce bleeding during and after surgery (change in hemoglobin from before surgery to lowest value after surgery within 30 days) * Does TXA reduce bleeding complications within 30 days of surgery (blood transfusion, return to the operating room or procedural inter... Read More
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
04/25/2025
Locations: Cleveland Clinic Fairview Hospital, Cleveland, Ohio
Conditions: Bleeding, Colorectal Disorders, Thromboembolism, Tranexamic Acid
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease
Recruiting
The primary objective of the FALCON study is to evaluate the efficacy of KL1333 on selected disease manifestations of primary mitochondrial disease (PMD) following 48 weeks of treatment. This objective involves evaluating the efficacy of KL1333 versus placebo on fatigue symptoms and impacts on daily living as well as on functional lower extremity strength and endurance. Additionally, the study evaluates the safety and tolerability of KL1333.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/24/2025
Locations: Akron Children's Hospital, Akron, Ohio +17 locations
Conditions: Primary Mitochondrial Disease
A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control
Recruiting
The objective of this study is to explore the safety and efficacy of SHJ002 Sterile Ophthalmic Solution relative to atropine in myopia control SHJ002 is an antisense oligonucleotide to neutralize a specific microRNA.
Gender:
ALL
Ages:
Between 3 years and 12 years
Trial Updated:
04/24/2025
Locations: Pacific Center for Advanced Vision Care Tanasbourne Vision Center, Hillsboro, Ohio +7 locations
Conditions: Myopia, Progressive
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK) for Relapsed & Refractory Acute Myeloid Leukemia (AML)
Recruiting
The objective of this study is to demonstrate that cytokine-induced memory-like natural killer cells can be generated from donor cells and infused safely into patients with relapsed or refractory acute myeloid leukemia (AML). A secondary objective is to assess efficacy of the CIML-NK cells in treating AML.
Gender:
ALL
Ages:
2 years and above
Trial Updated:
04/23/2025
Locations: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Conditions: Acute Myeloid Leukemia
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
Recruiting
A pilot study to evaluate and compare glucose metrics using a real-time continuous glucose monitor (FreeStyle Libre 3 sensor) between patients with diabetes and gastroparesis and those with diabetes without gastroparesis.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/23/2025
Locations: Cleveland Clinic Foundation, Cleveland, Ohio
Conditions: Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1, Gastroparesis With Diabetes Mellitus
Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation
Recruiting
Alemtuzumab is an antibody that reduces the strength of the immune system that is given in preparation for allogeneic hematopoietic cell transplant (HCT). In this research study the investigators want to find out if they can adjust the dose of alemtuzumab used as part of allogeneic HCT to target the level of Day 0 (the planned day of graft infusion) to an optimal therapeutic window of 0.15-0.9 ug/mL.
Gender:
ALL
Ages:
Between 6 weeks and 30 years
Trial Updated:
04/23/2025
Locations: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Conditions: Allogeneic Hematopoietic Cell Transplantation
Mirdametinib in Histiocytic Disorders
Recruiting
The purpose of this study is to see if treatment with mirdametinib in patients with Langerhans cell histiocytosis (LCH) or other histiocytic disorders will be better than current treatments and with fewer side effects.
Gender:
ALL
Ages:
2 years and above
Trial Updated:
04/23/2025
Locations: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
Conditions: Langerhans Cell Histiocytosis (LCH), Juvenile Xanthogranuloma (JXG), Rosai-Dorfman Disease (RDD), Histiocytic Disorders
Functional Brain Network Changes in Patients Undergoing Deep Brain Stimulation for Essential Tremor
Recruiting
The purpose of this study is to collect electrophysiological data related to functional brain network changes in patients undergoing deep brain stimulation for the treatment of essential tremor. Participants will either 1) have electroencephalography (EEG) scalp electrodes placed, or 2) remain seated with their head inside of a magnetoencephalography (MEG) recording system, as resting-state and task-related data are acquired. Spontaneous electrophysiological activity will be recorded in both the... Read More
Gender:
ALL
Ages:
Between 30 years and 80 years
Trial Updated:
04/23/2025
Locations: Cleveland Clinic, Cleveland, Ohio
Conditions: Essential Tremor
Effects of Lavender Aromatherapy on Patient Anxiety During Mohs Micrographic Surgery
Recruiting
This study aims to improve patient comfort by exploring the potential of lavender aromatherapy in reducing anxiety and unpleasant odor perception during Mohs Micrographic Surgery (MMS). Lavender has been widely studied for its sedative-like properties and calming effects, both in medical and dental settings. By investigating the impact of lavender aromatherapy on patient anxiety levels during MMS, we seek to provide evidence-based insights into non- pharmacological interventions that can enhanc... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/21/2025
Locations: University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio
Conditions: Skin Cancer, Skin Carcinoma
FMRI of Patients Receiving IV Ketamine for Treatment Resistant Bipolar Depression
Recruiting
This is a prospective open-label observational study of patients with treatment resistant bipolar depression referred for intravenous ketamine, with an interventional component of fMRI.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
04/17/2025
Locations: Cleveland Clinic Lutheran Hospital, Cleveland, Ohio +1 locations
Conditions: Bipolar Depression, Treatment Resistant Bipolar Depression
Abdominal Wall Tension in Patients Undergoing Ventral Hernia Repair Without Component Separation
Recruiting
The purpose of this study is to use a scale to learn more about the tension of the abdominal wall in hernia repairs without component separation. 1. What is the abdominal wall tension for hernias repaired without a component separation? 2. What patient factors contribute to greater abdominal wall tension? 3. Is there an association between abdominal wall tension before primary closure or bridging repair and patient outcomes? Participants will be asked to allow their surgeon to use a tension sc... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/17/2025
Locations: Cleveland Clinic Foundation, Cleveland, Ohio
Conditions: Hernia, Ventral, Hernia, Abdominal, Hernia Abdominal Wall